Clinical Trials Directory

Trials / Completed

CompletedNCT05692687

A Post-market Clinical Study to Evaluate the Safety and Performance of the Carbon Fibre Reinforced Polyetheretherketone Metatarso-Phalangeal (MTP) Plate (CoLink® PCR MTP Plate) for the Treatment of Hallux Rigidus

A Prospective, Non-comparative, Multi-centre, Post-market Clinical Study to Evaluate the Safety and Performance of the Carbon Fibre Reinforced Polyetheretherketone Metatarso-Phalangeal (MTP) Plate (CoLink® PCR MTP Plate) for the Treatment of Hallux Rigidus

Status
Completed
Phase
Study type
Observational
Enrollment
18 (actual)
Sponsor
Invibio Ltd · Industry
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

The clinical study involves the routine treatment of skeletally mature patients who have been diagnosed with hallux rigidus (stiffness of the first metatarso-phalangeal joint in the foot due to arthritis and degeneration of cartilage). It follows standard practice surgery to treat this condition. This type of degenerative arthritis affects the joint of the big toe (hallux) which is attached to the foot. Taking part in this research will involve collecting data of the surgery to remove damaged cartilage and fix the two bones together with screws and a plate (called the CoLink® PCR MTP Plate).

Conditions

Timeline

Start date
2023-03-15
Primary completion
2025-08-12
Completion
2025-08-12
First posted
2023-01-20
Last updated
2025-11-19

Locations

3 sites across 1 country: United States

Source: ClinicalTrials.gov record NCT05692687. Inclusion in this directory is not an endorsement.